| 1 | 4-Cl-Bn7GpppG mRNA 5' cap analog | OYW |
 |
1 |
| 2 | (3R,4R)-1-METHANESULFONYL-PYRROLIDINE-3,4-DICARBOXYLIC ACID 3-[(4-CHLORO-3-FLUORO-PHENYL)-AMIDE] 4-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYL]-AMIDE} | OYJ |
 |
1 |
| 3 | bn7GpppG mRNA 5' cap analog | OYE |
 |
1 |
| 4 | 3-[(2~{R},5~{S})-2-(2,5-dimethylphenyl)-5-methyl-morpholin-4-yl]propane-1-sulfonamide | OXB |
 |
1 |
| 5 | (2~{R},5~{S})-2-(2-chlorophenyl)-5-methyl-morpholine | OWZ |
 |
1 |
| 6 | ~{N}-ethyl-2-[(2~{S},5~{R})-5-methyl-2-phenyl-morpholin-4-yl]ethanamine | OUZ |
 |
1 |
| 7 | (2~{R})-2-(3-fluorophenyl)-5,5-dimethyl-morpholine | OUQ |
 |
1 |
| 8 | L-ornithine | ORN |
 |
2 |
| 9 | 1-[(1S)-4-carbamimidamido-1-carboxybutyl]-5-oxo-D-proline | OP1 |
 |
1 |
| 10 | 2-[2-[[[(4~{R},8~{S},11~{S})-11-azanyl-8-[(4-hydroxyphenyl)methyl]-6,10-bis(oxidanylidene)-1,2-dithia-5,9-diazacyclotridec-4-yl]carbonylamino]methyl]phenyl]ethanoic acid | ONN |
 |
1 |
| 11 | 4-(ethylamino)-6-[(propan-2-yl)amino]-1,3,5-triazin-2-ol | OKM |
 |
1 |
| 12 | (1R,5S)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL (2R)-3-HYDROXY-2-PHENYLPROPANOATE | OIN |
 |
2 |
| 13 | N-OXALYLGLYCINE | OGA |
 |
251 |
| 14 | 3-(3-HYDROXY-BENZOYLOXY)-8-METHYL-8-AZA-BICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID | OBE |
 |
1 |
| 15 | 2-[4-(4-cyano-3-methylphenoxy)phenyl]-N-ethyl-N-[2-(1H-pyrazol-1-yl)ethyl]acetamide | OAV |
 |
1 |
| 16 | (3~{a}~{S})-2-[(3~{S})-1-azabicyclo[2.2.2]octan-3-yl]-3~{a},4,5,6-tetrahydro-3~{H}-benzo[de]isoquinolin-1-one | O7B |
 |
1 |
| 17 | 4-[[5-[7-chloranyl-3-(1~{H}-indazol-6-yl)benzotriazol-5-yl]pyrazol-1-yl]methyl]benzenecarbonitrile | O1H |
 |
1 |
| 18 | [[(2~{R},3~{S},4~{R},5~{R})-5-(6-azanyl-2-diazanyl-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]methylphosphonic acid | O02 |
 |
1 |